Paper33780474
Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
Matsuo S and 6 others. PLoS One, 2021. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification. Papers, record 33780474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33780474
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Down Syndrome | Major topic |
| GATA1 Transcription Factor | Major topic |
| Hematopoiesis | Major topic |
| Human Embryonic Stem Cells | Major topic |
| Cell Differentiation | |
| Cell Line | |
| Cell Lineage | |
| Doxycycline | |
| Humans | |
| Leukemia, Megakaryoblastic, Acute | |
| Leukemoid Reaction | |
| Megakaryocytes | |
| Myeloid Cells | |
| Signal Transduction | |
| Transfection | |
| Trisomy |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15895080 | Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. | Nat Genet | 2005 | https://conductscience.org/library/papers/15895080 | PubMed |
| 2 | 27510823 | Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update. | Curr Hematol Malig Rep | 2016 | https://conductscience.org/library/papers/27510823 | PubMed |
| 3 | 18182574 | Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. | Blood | 2008 | https://conductscience.org/library/papers/18182574 | PubMed |
| 4 | 14684662 | Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome. | Blood | 2004 | https://conductscience.org/library/papers/14684662 | PubMed |
| 5 | 10216081 | Consequences of GATA-1 deficiency in megakaryocytes and platelets. | Blood | 1999 | https://conductscience.org/library/papers/10216081 | PubMed |
| 6 | 29731430 | Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress. | Stem Cell Reports | 2018 | https://conductscience.org/library/papers/29731430 | PubMed |
| 7 | 30664903 | Application of induced pluripotent stem cells to primary immunodeficiency diseases. | Exp Hematol | 2019 | https://conductscience.org/library/papers/30664903 | PubMed |
| 8 | 2320113 | Megakaryocytic and erythrocytic lineages share specific transcription factors. | Nature | 1990 | https://conductscience.org/library/papers/2320113 | PubMed |
| 9 | 24336126 | GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia. | Leukemia | 2014 | https://conductscience.org/library/papers/24336126 | PubMed |
| 10 | 7823932 | The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. | Mol Cell Biol | 1995 | https://conductscience.org/library/papers/7823932 | PubMed |
| 11 | 25621499 | Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus. | J Clin Invest | 2015 | https://conductscience.org/library/papers/25621499 | PubMed |
| 12 | 32354872 | Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation. | Haematologica | 2021 | https://conductscience.org/library/papers/32354872 | PubMed |
| 13 | 17576817 | Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. | Blood | 2007 | https://conductscience.org/library/papers/17576817 | PubMed |
| 14 | 19594743 | Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. | Br J Haematol | 2009 | https://conductscience.org/library/papers/19594743 | PubMed |
| 15 | 24056718 | The landscape of somatic mutations in Down syndrome-related myeloid disorders. | Nat Genet | 2013 | https://conductscience.org/library/papers/24056718 | PubMed |
| 16 | 12649131 | Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. | Blood | 2003 | https://conductscience.org/library/papers/12649131 | PubMed |
| 17 | 26971820 | CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. | Cell Stem Cell | 2016 | https://conductscience.org/library/papers/26971820 | PubMed |
| 18 | 2276623 | Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. | Genes Dev | 1990 | https://conductscience.org/library/papers/2276623 | PubMed |
| 19 | 21849481 | Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. | Blood | 2011 | https://conductscience.org/library/papers/21849481 | PubMed |
| 20 | 12586620 | GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. | Blood | 2003 | https://conductscience.org/library/papers/12586620 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42275564 | RUNX1+23 enhancer marks erythro-megakaryocyte lineages in early waves of hematopoiesis in human ESC differentiation. | Blood Adv | 2026 | https://conductscience.org/library/papers/42275564 | PubMed |
| 41841596 | Quantitative analysis of DNA-GATA1 binding alterations linked to hematopoietic disorders. | FEBS J | 2026 | https://conductscience.org/library/papers/41841596 | PubMed |
| 40680731 | Single-cell transcriptomics reveal individual and cooperative effects of trisomy 21 and GATA1s on hematopoiesis. | Stem Cell Reports | 2025 | https://conductscience.org/library/papers/40680731 | PubMed |
| 39634136 | Microcell-mediated chromosome transfer between non-identical human iPSCs. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/39634136 | PubMed |
| 39118322 | Pediatric Tumors as Disorders of Development: The Case for In Vitro Modeling Based on Human Stem Cells. | Cancer Control | 2024 | https://conductscience.org/library/papers/39118322 | PubMed |
| 39017848 | GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/39017848 | PubMed |
| 38409186 | The abundance of the short GATA1 isoform affects megakaryocyte differentiation and leukemic predisposition in mice. | Exp Hematol Oncol | 2024 | https://conductscience.org/library/papers/38409186 | PubMed |
| 37377909 | Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy. | Front Oncol | 2023 | https://conductscience.org/library/papers/37377909 | PubMed |
| 36035173 | Advances in molecular characterization of myeloid proliferations associated with Down syndrome. | Front Genet | 2022 | https://conductscience.org/library/papers/36035173 | PubMed |
| 35326734 | Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35326734 | PubMed |
| 34685678 | Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies. | Cells | 2021 | https://conductscience.org/library/papers/34685678 | PubMed |
| 34439298 | The Mutational Landscape of Myeloid Leukaemia in Down Syndrome. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439298 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33780474
GET https://conductscience.org/api/papers/v1/33780474/references?page=2